Eton Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Eton Pharmaceuticals (ETON).

Price Target Range — 9 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$56Upside to Avg. PT+0.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Canaccord Genuity	Gary Nachman	PT Raise	Buy	$60→$68
Aug 14, 2026	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$40→$70
Aug 14, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$65→$70
Aug 11, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$57→$65
Jul 28, 2026	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$40→$62
Jul 17, 2026	Canaccord Genuity	Gary Nachman	Initiate	Buy	$60
May 15, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$52→$57
Mar 20, 2026	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$26→$31
Mar 20, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$37→$52
Mar 20, 2026	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$30→$35
Mar 3, 2026	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$29→$30
Mar 2, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$35→$37
May 29, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$33→$35
May 16, 2025	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$24→$26
May 14, 2025	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$26→$28
Mar 19, 2025	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$23→$26
Mar 19, 2025	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$21→$24
Mar 19, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$33
Jan 23, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$17→$33
Jan 10, 2025	B. Riley Securities	Madison El-Saadi	Initiate	Buy	$21

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

Canaccord Genuity analyst Gary Nachman maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $60 to $68.

Benzinga Newsdesk

PRO
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $40 to $70.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $65 to $70.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $57 to $65.

Benzinga Newsdesk

PRO
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $40 to $62.

Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On Eton Pharmaceuticals with Buy Rating, Announces Price Target of $60

Canaccord Genuity analyst Gary Nachman initiates coverage on Eton Pharmaceuticals (NASDAQ:ETON) with a Buy rating and announces Price Target of $60.

Benzinga Newsdesk

Eton Pharmaceuticals Inc

Eton Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

PRO
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

PRO
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

PRO
Canaccord Genuity Initiates Coverage On Eton Pharmaceuticals with Buy Rating, Announces Price Target of $60

People Also Watch

People Also Watch

Eton Pharmaceuticals Inc

Eton Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

PROB. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

PROHC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

PROHC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

PROCraig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

PROCanaccord Genuity Initiates Coverage On Eton Pharmaceuticals with Buy Rating, Announces Price Target of $60

People Also Watch

People Also Watch

PRO
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

PRO
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

PRO
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

PRO
Canaccord Genuity Initiates Coverage On Eton Pharmaceuticals with Buy Rating, Announces Price Target of $60